NASDAQ:TBPH | ROE | Theravance Biopharma, Inc.

Complete source-backed roe history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3018.57%
2026-03-3139.42%
2025-12-3135.69%
2025-09-3012.61%
2025-06-305.80%
2025-03-31-35.14%
2024-12-31-32.14%
2024-09-30-26.61%
2024-06-30-23.57%
2024-03-31-21.85%
2023-12-31-25.91%
2023-09-30-23.18%
2023-06-30310.01%
2023-03-31236.40%
2022-12-31197.40%
2022-09-30176.97%
2022-06-3029.01%
2022-03-3141.45%
2021-12-3158.90%
2021-09-3069.79%
2021-06-3087.94%
2021-03-3173.59%
2020-12-3191.53%
2020-09-30109.04%
2020-06-30133.43%
2020-03-31156.35%
2019-12-31105.64%
2019-09-30120.91%
2019-06-30161.81%
2019-03-31196.92%
2018-12-31417.77%
2018-09-301876.24%
2018-06-30-755.24%
2018-03-31-449.75%
2017-12-31-247.79%
2017-09-30-144.37%
2017-06-30-96.59%
2017-03-31-72.75%
2016-12-31-54.44%
2016-09-30-56.45%
2016-06-30-56.44%
2016-03-31-76.25%
2015-12-31-74.97%
2015-09-30-90.63%
2015-06-30-81.06%
2015-03-31-75.92%
2014-12-31-81.80%
2014-09-30-63.80%
2014-06-30-52.86%
2014-03-311027.73%
2013-12-31917.43%

Annual ROE

DateROE
2025-12-3135.69%
2024-12-31-32.14%
2023-12-31-25.91%
2022-12-31197.40%
2021-12-3158.90%
2020-12-3191.53%
2019-12-31105.64%
2018-12-31417.77%
2017-12-31-247.79%
2016-12-31-54.44%
2015-12-31-74.97%
2014-12-31-81.80%
2013-12-31917.43%
2012-12-31136.98%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.